CVS Health Corporation Financial Ratios — CVS.DE Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	16.71	16.4	17.16	15.38	15.54	14.27	11.55	-0.73	7.48	7.67	8.06	4.17	7.76	4.14	1.58
Return on Assets (%)	5.46	5.91	6.67	6.37	6.29	5.69	6.99	-0.41	3.17	3.17	3.45	1.87	3.49	1.83	0.7
Return on Capital (%)	12.42	12.57	12.79	11.57	10.68	9.23	8.83	-1.3	5.21	5.14	5.5	3.38	5.64	3.55	2.24
Return on Invested Capital (%)	8.02	9.26	9.94	10.42	9.96	9.92	12.08	-4.38	6.32	6.66	7.48	8.22	7.33	4.6	5.35
Gross Margin (%)	19.2	18.27	18.76	18.2	17.31	16.24	15.44	16.21	17.73	18.25	17.84	16.9	15.21	13.79	13.77
EBITDA Margin (%)	7.38	7.28	7.82	7.7	7.55	7.24	6.6	6.62	6.46	6.83	6.7	6.36	5.3	3.83	3.73
Operating Margin (%)	5.91	5.86	6.34	6.31	6.18	5.85	5.26	5.23	4.76	5.18	5.17	5.05	4.08	2.6	2.58
Incremental Operating Margin (%)	1.72	5.48	22.71	6.04	4.86	3.76	-9.21	4.61	3.29	14.19	5.08	3.92	-4.79	-32.62	2.36
Pretax Margin (%)	5.37	5.12	5.94	5.51	5.62	4.86	4.47	0.72	3.5	3.64	3.61	1.81	3.12	1.65	0.53
Profit Margin (%)	3.23	3.14	3.62	3.33	3.42	2.99	3.58	-0.31	2.58	2.67	2.74	1.34	2.33	1.24	0.44
Net Income to Common Margin (%)	3.23	3.14	3.62	3.33	3.42	2.99	3.58	-0.31	2.58	2.67	2.74	1.34	2.33	1.24	0.44
Effective Tax Rate (%)	39.29	38.64	38.89	39.5	39.3	38.4	19.8	142.39	26.3	26.29	24.18	25.86	25.11	25.41	19.1
Dvd Payout Ratio (%)	19.34	21.44	23.85	27.73	30.12	34.57	30.9	-340.8	39.27	36.37	32.91	66.94	37.32	74	201.24
Sustainable Growth Rate (%)	13.48	12.88	13.07	11.12	10.86	9.34	7.98	-3.23	4.54	4.88	5.41	1.38	4.86	1.08	-1.6

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	10,014	9,828	13,402	12,890	27,464	27,531	27,002	73,429	89,002	85,042	75,999	70,732	79,385	82,920	79,950
ST Debt	806	695	561	1,260	1,197	1,916	4,821	1,985	5,377	7,078	5,851	3,456	4,713	7,494	5,805
LT Debt	9,208	9,133	12,841	11,630	26,267	25,615	22,181	71,444	83,625	77,964	70,148	67,276	74,672	75,426	74,145
Total Debt/EBITDA	1.27	1.1	1.35	1.2	2.37	2.14	2.21	5.7	5.37	4.63	3.88	3.45	4.19	5.8	5.33
Net Debt/EBITDA	1.09	0.94	0.94	0.97	2.16	1.88	2.07	5.38	3.79	3.09	2.39	1.92	2.82	4.04	3.74
Total Debt/EBIT	1.58	1.36	1.67	1.46	2.9	2.65	2.78	7.22	7.28	6.11	5.03	4.34	5.44	8.55	7.7
Net Debt/EBIT	1.36	1.17	1.16	1.18	2.64	2.33	2.6	6.82	5.14	4.08	3.1	2.41	3.66	5.95	5.4
EBITDA to Interest Expense	13.43	15.98	19.16	17.45	13.47	11.93	11.49	4.92	5.47	6.31	7.82	8.97	7.14	4.83	4.81
EBITDA-CapEx/Interest Expense	10.25	12.36	15.32	13.97	10.71	9.87	9.68	4.14	4.66	5.47	6.82	7.78	5.99	3.89	3.9
EBIT to Interest Expense	10.77	12.85	15.55	14.31	11.03	9.63	9.15	3.88	4.03	4.79	6.03	7.12	5.49	3.28	3.33
Interest Expense	588	561	517	615	859	1,078	1,062	2,619	3,035	2,907	2,503	2,287	2,658	2,958	3,119
Common Equity/Total Assets	34.25	37.78	39.86	42.95	38.43	41.29	79.52	43.95	40.94	41.68	43.9	45.82	44.29	44.43	44.02
Long-Term Debt/Equity (%)	24.2	24.26	33.85	30.64	70.6	69.54	58.84	122.04	130.32	111.85	93.06	93.74	97.44	99.6	98.36
Long-Term Debt/Capital (%)	28.64	26.21	30.64	25.98	41.7	38.5	21.61	44.63	46.36	42.95	39.28	38.31	39.27	38.56	38.67
Long-Term Debt/Total Assets (%)	14.27	13.79	17.95	15.68	28.42	27.12	23.32	36.37	37.59	33.79	30.11	29.47	29.9	29.79	29.24
Total Debt/Equity (%)	26.32	26.1	35.33	33.95	73.82	74.74	71.63	125.43	138.7	122.01	100.82	98.56	103.59	109.49	106.06
Total Debt/Capital (%)	31.15	28.21	31.98	28.8	43.6	41.38	26.3	45.87	49.34	46.85	42.56	40.27	41.75	42.4	41.7
Total Debt/Total Assets (%)	15.52	14.84	18.74	17.38	29.71	29.15	28.38	37.38	40.01	36.86	32.62	30.99	31.79	32.75	31.53
Net Debt to Equity	22.6	22.45	24.55	27.42	67.21	65.59	67.13	118.49	97.86	81.48	62.04	54.77	69.7	76.17	74.44
Net Debt/Capital (%)	27.98	25.26	24.62	24.62	41.31	38.25	25.06	44.46	35.94	32.7	27.64	24.16	29.35	30.85	30.62
EBITDA	7,899	8,963	9,907	10,730	11,567	12,861	12,198	12,888	16,589	18,352	19,585	20,514	18,965	14,292	14,991
EBITDA-CapEx	6,027	6,933	7,923	8,594	9,200	10,637	10,280	10,851	14,132	15,915	17,065	17,787	15,934	11,511	12,159
Operating Income (Loss)	6,331	7,210	8,037	8,799	9,475	10,386	9,719	10,170	12,218	13,911	15,099	16,290	14,599	9,695	10,385

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.12	0.1	0.27	0.13	0.11	0.13	0.06	0.15	0.15	0.18	0.18	0.23	0.14	0.13	0.12
Current Ratio	1.56	1.42	1.64	1.37	1.26	1.18	1.02	1.03	0.94	0.91	0.88	0.95	0.86	0.81	0.84
Quick Ratio	0.62	0.56	0.84	0.64	0.62	0.6	0.49	0.55	0.52	0.53	0.55	0.62	0.59	0.56	0.57
CFO/Avg Current Liab	0.51	0.51	0.39	0.47	0.4	0.41	0.28	0.24	0.26	0.28	0.28	0.24	0.18	0.11	0.12
Common Equity/Total Assets	34.25	37.78	39.86	42.95	38.43	41.29	79.52	43.95	40.94	41.68	43.9	45.82	44.29	44.43	44.02
Long-Term Debt/Equity (%)	24.2	24.26	33.85	30.64	70.6	69.54	58.84	122.04	130.32	111.85	93.06	93.74	97.44	99.6	98.36
Long-Term Debt/Capital (%)	28.64	26.21	30.64	25.98	41.7	38.5	21.61	44.63	46.36	42.95	39.28	38.31	39.27	38.56	38.67
Long-Term Debt/Total Assets (%)	14.27	13.79	17.95	15.68	28.42	27.12	23.32	36.37	37.59	33.79	30.11	29.47	29.9	29.79	29.24
Total Debt/Equity (%)	26.32	26.1	35.33	33.95	73.82	74.74	71.63	125.43	138.7	122.01	100.82	98.56	103.59	109.49	106.06
Total Debt/Capital (%)	31.15	28.21	31.98	28.8	43.6	41.38	26.3	45.87	49.34	46.85	42.56	40.27	41.75	42.4	41.7
Total Debt/Total Assets (%)	15.52	14.84	18.74	17.38	29.71	29.15	28.38	37.38	40.01	36.86	32.62	30.99	31.79	32.75	31.53
CFO/Total Liabilities	22.1	23.35	17.22	22.46	15.46	17.6	13.94	6.43	8.12	9.85	11.59	10.34	7.76	5.13	5.97
CFO/CapEx	3.13	3.29	2.91	3.81	3.61	4.56	4.17	4.35	5.23	6.51	7.25	5.93	4.43	3.27	3.76
Altman's Z-Score	8.04	8.2	7.41	7.37	6.69	7.01	7.16	3.81	3.61	3.48	3.8	4.07	4.06	3.71	3.89

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	19.52	19.66	16.67	15.14	14.21	14.76	18.4	23.33	28.32	28.12	28.92	29.15	26.23	24.66	26
Days Sales Outstanding	18.7	18.57	21.9	24.12	25.69	24.72	19.84	15.65	12.89	12.98	12.62	12.52	13.92	14.8	14.04
Inventory Turnover	8.34	9.55	9.33	9.92	9.78	10.34	10.4	10.27	12.44	12.2	13.24	14.54	16.35	17.79	18.56
Days Inventory Outstanding	43.75	38.23	39.13	36.78	37.33	35.3	35.1	35.53	29.34	29.92	27.57	25.1	22.33	20.52	19.66
Accounts Payable Turnover	20.45	21.53	19.4	19	18.36	19.37	18.66	18.46	21.87	20.4	20.21	19.67	20.33	20.88	20.75
Accounts Payable Turnover Days	17.84	16.95	18.82	19.21	19.88	18.85	19.56	19.77	16.69	17.89	18.06	18.56	17.95	17.48	17.59
Cash Conversion Cycle	44.61	39.84	42.21	41.68	43.13	41.17	35.38	31.41	25.54	25.01	22.13	19.06	18.29	17.84	16.11
Inventory to Cash Days	-25.05	-19.66	-17.23	-12.66	-11.65	-10.57	-15.26	-19.89	-16.45	-16.94	-14.95	-12.57	-8.41	-5.72	-5.62
Inventories	10,046	11,032	11,045	11,930	14,001	14,760	15,296	16,450	17,516	18,496	17,760	19,090	18,025	18,107	19,246
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	10,046	11,032	11,045	11,930	14,001	14,760	15,296	16,450	17,516	18,496	17,760	19,649	18,632	18,107	19,246

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	93,806	90,886	90,849	76,368	66,117	61,053	66,245	64,615	94,977	89,418	136,627	122,857	101,381	55,655	101,350
- Cash & Cash Equivalents	1,413	1,375	4,089	2,481	2,459	3,371	1,696	4,059	5,683	7,854	9,408	12,945	8,196	8,586	8,453
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	30	- -	- -	5	7	4	4	318	306	312	306	300	175	170	168
+ Total Debt	10,014	9,828	13,402	12,890	27,464	27,531	27,002	73,429	89,002	85,042	75,999	70,732	79,385	82,920	79,950
Enterprise Value	102,432	99,334	100,074	86,748	91,041	85,130	91,444	131,781	176,229	163,918	200,407	178,166	169,486	127,752	170,870
Total Capital	32,150	34,843	41,912	44,761	62,994	66,535	102,658	160,098	180,388	181,507	178,588	175,623	190,156	195,588	191,716
Total Debt/Capital (%)	31.15	28.21	31.98	28.8	43.6	41.38	26.3	45.87	49.34	46.85	42.56	40.27	41.75	42.4	41.7
Total Debt / EV	0.1	0.1	0.13	0.15	0.3	0.32	0.3	0.56	0.51	0.52	0.38	0.4	0.47	0.65	0.47
EV/Sales	0.96	0.81	0.79	0.62	0.59	0.48	0.49	0.68	0.69	0.61	0.69	0.55	0.47	0.34	0.42
EV/EBITDA	12.97	11.08	10.1	8.08	7.87	6.62	7.5	10.23	10.62	8.93	10.23	8.69	8.94	8.94	11.4
EV/EBIT	16.18	13.78	12.45	9.86	9.61	8.2	9.41	12.96	14.42	11.78	13.27	10.94	11.61	13.18	16.45
EV/Cash Flow to Firm	16.49	14.16	16.41	10.19	10.05	7.88	10.32	16.99	11.68	9.1	9.94	9.97	10.99	11.29	12.98
EV/Free Cash Flow to Firm	12.67	10.98	12.38	8.15	7.97	6.53	8.49	13.46	10.05	8.02	8.84	8.65	9.19	9.06	10.68
Diluted Market Cap	94,437	91,530	91,521	76,894	66,590	61,394	66,505	64,615	95,269	89,760	137,663	123,887	101,776	55,788	101,670
Diluted Enterprise Value	103,068	99,983	100,834	87,308	91,602	85,558	91,815	134,303	178,894	167,260	204,560	181,974	173,140	130,292	173,335
EV per Share	76.56	78.15	82.23	74.72	81.43	79.34	89.65	126.23	135.46	125.22	151.94	135.8	131.9	101.47	134.86
TTM Sales	107,080	123,120	126,761	139,367	153,290	177,546	184,786	194,579	256,776	268,706	292,111	322,467	357,776	372,809	402,067
TTM EBITDA	7,899	8,963	9,907	10,730	11,567	12,861	12,198	12,888	16,589	18,352	19,585	20,514	18,965	14,292	14,991
TTM Operating Income	6,331	7,210	8,037	8,799	9,475	10,386	9,719	10,170	12,218	13,911	15,099	16,290	14,599	9,695	10,385
TTM Cash Flow to Firm	6,213	7,015	6,099	8,509	9,060	10,805	8,859	7,755	15,085	18,008	20,163	17,873	15,417	11,313	13,162
TTM Free Cash Flow to Firm	8,085	9,045	8,083	10,645	11,427	13,029	10,777	9,792	17,542	20,445	22,683	20,600	18,448	14,094	15,994

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	12.22	10.52	11.78	7.49	6.11	4.97	6.7	5.93	6.22	4.9	6.62	6.55	6.18	4.69	7.55
EV/EBIT	16.18	13.78	12.45	9.86	9.61	8.2	9.41	12.96	14.42	11.78	13.27	10.94	11.61	13.18	16.45
Enterprise Value	102,432	99,334	100,074	86,748	91,041	85,130	91,444	131,781	176,229	163,918	200,407	178,166	169,486	127,752	170,870
Low Price	64.3	65.25	69.13	65.74	56.74	56.19	56.29	60.69	59.33	52.82	67.54	85.85	64.64	43.15	44.35
EV/Sales	0.96	0.81	0.79	0.62	0.59	0.48	0.49	0.68	0.69	0.61	0.69	0.55	0.47	0.34	0.42
EV/EBITDA	12.97	11.08	10.1	8.08	7.87	6.62	7.5	10.23	10.62	8.93	10.23	8.69	8.94	8.94	11.4
Price/Earnings	27.1	23.52	19.78	16.44	12.62	11.48	10	- -	14.32	12.46	17.08	28.5	12.15	12.06	57.32
Price/Earnings Average	28.13	22.87	19.04	17.98	12.82	12.08	9.42	-112.29	12.38	11.73	13.64	30.29	11.45	17.31	48.81
Price/Earnings High	30.72	23.95	19.79	18.85	13.86	12.59	10.03	-118.93	15.18	13.94	17.1	34.01	14.51	22.57	61.23
Price/Earnings Low	24.85	21.46	18.32	16.43	12.11	11.34	8.67	-106.66	11.64	9.63	11.13	26.13	9.95	11.77	31.78
Price/Book Value	4.24	3.63	3.19	2.4	1.86	1.57	0.88	0.75	1.04	0.93	1.34	1.17	0.92	0.49	0.91
Price/Book Value Average	4.41	3.53	3.07	2.62	1.89	1.65	0.82	0.77	0.9	0.88	1.07	1.25	0.86	0.71	0.77
Price/Book Value High	4.81	3.7	3.19	2.75	2.04	1.72	0.88	0.82	1.11	1.04	1.34	1.4	1.09	0.93	0.97
Price/Book Value Low	3.89	3.32	2.95	2.4	1.79	1.55	0.76	0.73	0.85	0.72	0.87	1.08	0.75	0.48	0.5
Price/Tangible Book Value	54.41	60.39	48.66	1,624.84	-4.47	-4.09	-4.6	-1.14	-1.95	-2.18	-4.17	-3.94	-2.31	-1.3	-2.85
Price/Tangible Book Value Average	56.5	58.71	46.83	1,776.97	-4.54	-4.3	-4.33	-1.18	-1.69	-2.05	-3.33	-4.19	-2.18	-1.86	-2.42
Price/Tangible Book Value High	61.68	61.48	48.67	1,862.05	-4.91	-4.48	-4.62	-1.25	-2.07	-2.44	-4.17	-4.7	-2.76	-2.43	-3.04
Price/Tangible Book Value Low	49.9	55.1	45.06	1,623.85	-4.29	-4.04	-3.99	-1.12	-1.59	-1.69	-2.72	-3.61	-1.89	-1.27	-1.58
Price/Sales	0.88	0.74	0.72	0.55	0.43	0.34	0.36	0.33	0.37	0.33	0.47	0.38	0.28	0.15	0.25
Price/Sales Average	0.91	0.72	0.69	0.6	0.44	0.36	0.34	0.34	0.32	0.31	0.37	0.4	0.27	0.21	0.21
Price/Sales High	0.99	0.75	0.72	0.63	0.47	0.38	0.36	0.36	0.39	0.37	0.47	0.45	0.34	0.28	0.27
Price/Sales Low	0.8	0.67	0.66	0.55	0.41	0.34	0.31	0.33	0.3	0.26	0.3	0.35	0.23	0.15	0.14
Price/Cash Flow	16.02	13.62	15.71	9.39	7.74	6.02	8.27	7.29	7.39	5.64	7.48	7.59	7.55	6.11	9.53
Price/Cash Flow Average	16.63	13.24	15.12	10.26	7.86	6.34	7.79	7.52	6.39	5.31	5.97	8.07	7.11	8.77	8.11
Price/Cash Flow High	18.16	13.87	15.71	10.76	8.5	6.6	8.29	7.97	7.84	6.31	7.49	9.06	9.02	11.43	10.17
Price/Cash Flow Low	14.69	12.43	14.55	9.38	7.43	5.95	7.17	7.15	6.01	4.36	4.88	6.96	6.19	5.96	5.28
Price/Free Cash Flow Average	12.69	10.23	11.34	8.19	6.2	5.22	6.31	6.12	5.38	4.62	5.29	6.96	5.83	6.73	6.43
Price/Free Cash Flow High	13.85	10.71	11.79	8.58	6.7	5.44	6.72	6.48	6.6	5.49	6.63	7.82	7.39	8.78	8.06
Price/Free Cash Flow Low	11.21	9.6	10.91	7.48	5.86	4.9	5.81	5.81	5.06	3.79	4.32	6.01	5.07	4.58	4.18
EV/Sales Average	0.99	0.79	0.76	0.67	0.6	0.5	0.47	0.7	0.65	0.6	0.6	0.59	0.47	0.41	0.39
EV/Sales High	1.07	0.82	0.79	0.7	0.64	0.51	0.5	0.72	0.72	0.66	0.7	0.63	0.54	0.48	0.45
EV/Sales Low	0.88	0.74	0.74	0.62	0.58	0.48	0.45	0.68	0.63	0.55	0.53	0.53	0.43	0.35	0.32
EV/EBITDA Average	13.42	10.8	9.77	8.75	7.97	6.87	7.19	10.58	9.99	8.81	8.99	9.2	8.8	10.8	10.54
EV/EBITDA High	14.56	11.27	10.11	9.13	8.44	7.08	7.52	10.89	11.11	9.68	10.4	9.98	10.15	12.5	12
EV/EBITDA Low	11.98	10.2	9.43	8.08	7.65	6.57	6.78	10.32	9.69	7.99	7.96	8.32	8.14	9.01	8.53
EV/EBIT Average	16.75	13.43	12.04	10.68	9.72	8.51	9.02	13.41	13.57	11.63	11.66	11.58	11.43	15.92	15.21
EV/EBIT High	18.16	14.01	12.47	11.13	10.3	8.77	9.44	13.8	15.09	12.77	13.49	12.57	13.18	18.42	17.32
EV/EBIT Low	14.95	12.67	11.63	9.86	9.34	8.13	8.51	13.08	13.16	10.54	10.33	10.48	10.58	13.29	12.31
Last Price	70.11	71.51	74.65	65.78	59.14	56.9	64.95	61.89	73	68.31	103.58	93.64	78.9	44.21	79.99
High Price	79.48	72.8	74.67	75.38	64.92	62.37	65.11	67.67	77.42	76.47	103.7	111.77	94.22	82.7	85.44
Enterprise Value Average	106,033	96,806	96,750	93,932	92,143	88,411	87,672	136,390	165,786	161,723	176,012	188,646	166,884	154,352	157,954
Enterprise Value High	114,974	100,982	100,185	97,930	97,590	91,091	91,720	140,334	184,347	177,594	203,677	204,725	192,440	178,619	179,915
Enterprise Value Low	94,660	91,380	93,446	86,735	88,453	84,453	82,725	133,046	160,815	146,638	155,987	170,717	154,425	128,824	127,854

Shares Outstanding	1,298	1,231	1,180	1,140	1,101	1,061	1,014	1,295	1,302	1,310	1,322	1,300	1,288	1,260	1,271
Diluted Weighted Avg Shares	1,347	1,280	1,226	1,169	1,126	1,079	1,024	1,044	1,305	1,314	1,329	1,323	1,290	1,262	1,271
Basic Weighted Avg Shares	1,338	1,271	1,217	1,161	1,118	1,073	1,020	1,044	1,301	1,309	1,319	1,312	1,285	1,259	1,267
Revenue per Share	80.03	96.87	104.16	120.04	137.11	165.47	181.16	186.38	197.37	205.28	221.46	245.78	278.42	296.12	317.34
EBITDA per Share	5.9	7.05	8.14	9.24	10.35	11.99	11.96	12.34	12.75	14.02	14.85	15.64	14.76	11.35	11.83
Operating Income per Share	4.73	5.67	6.6	7.58	8.47	9.68	9.53	9.74	9.39	10.63	11.45	12.42	11.36	7.7	8.2
Basic EPS, GAAP	2.59	3.04	3.77	4	4.68	4.96	6.49	-0.57	5.1	5.48	6.07	3.29	6.49	3.66	1.4
Basic EPS from Cont Ops	2.61	3.04	3.78	4	4.68	4.96	6.5	-0.57	5.1	5.5	6.06	3.3	6.51	3.64	1.36
Diluted EPS, GAAP	2.57	3.02	3.75	3.97	4.65	4.93	6.47	-0.57	5.08	5.46	6.02	3.26	6.47	3.66	1.39
Diluted EPS from Cont Ops	2.59	3.02	3.75	3.97	4.64	4.93	6.48	-0.57	5.08	5.48	6.01	3.27	6.49	3.63	1.36
Dividend per Share	0.5	0.65	0.9	1.11	1.41	1.71	2.01	1.95	2	2	1.99	2.22	2.44	2.68	2.68
Cash Flow per Share	4.38	5.25	4.75	7.01	7.64	9.45	7.85	8.49	9.88	12.12	13.85	12.33	10.45	7.23	8.4
Free Cash Flow per Basic Share	2.98	3.65	3.12	5.17	5.52	7.38	5.97	6.54	7.99	10.26	11.94	10.25	8.09	5.02	6.16
Cash & Equivalents per Share	1.06	1.09	3.43	2.17	2.28	3.22	1.77	6.3	6.19	8.29	9.5	11.98	8.91	8.73	8.36
Book Value per Share	16.52	19.68	23.43	27.45	31.77	36.35	74.17	82.71	70.01	73.46	77.55	79.72	86.07	89.36	88.08
Tangible Book Value per Share	1.29	1.18	1.53	0.04	-13.22	-13.91	-14.1	-54.27	-37.43	-31.32	-24.84	-23.77	-34.14	-34.05	-28.1

CVS Health Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)